Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

NCT05237258 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05237258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05237258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2022
Completion date
April 30, 2029
Enrollment
2,300 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

high risk acute myeloid leukemia, primary refractory acute myeloid leukemia, relapsed adult aml